Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Completed 756Unknown 349Recruiting 270Terminated 185Active not recruiting 111Not yet recruiting 96Withdrawn 70Enrolling by invitation 7Suspended 6No longer available 1

Sponsor Class

OTHER 6OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 1Peritoneal Neoplasms 1Ototoxicity 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Lung Neoplasms 1Hepatoblastoma 1Chemotherapeutic Agent Toxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Specimen Handling 11Cyclophosphamide 9Magnetic Resonance Spectroscopy 8pembrolizumab 6Cisplatin 6Bevacizumab 6Radiosurgery 5Oxaliplatin 5Nivolumab 5Irinotecan 5Fluorouracil 5Everolimus 5Capecitabine 5venetoclax 4Vincristine 4S 1 (combination) 4Prednisone 4Leucovorin 4Etoposide 4Drug Therapy 4Doxorubicin 4Azacitidine 4fludarabine phosphate 3fludarabine 3Tacrolimus 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Rituximab 3Radiotherapy 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Suspended × OTHER × Cisplatin × Clear all
NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

NCT05403723 2026-02-19

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

University of Maryland, Baltimore

Phase 1 Suspended
50 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT03875144 2026-02-09

MESOTIP

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2 Suspended
66 enrolled
Gynecologic

Peritoneal Neoplasms

NCT05756660 2025-10-20

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

Children's Hospital Medical Center, Cincinnati

Phase EARLY_PHASE1 Suspended
33 enrolled
Gastrointestinal

Ototoxicity, Neoplasms, Germ Cell and Embryonal, Hepatoblastoma

NCT00695032 2014-11-05

Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors

Institut Claudius Regaud

Phase NA Suspended
80 enrolled
Other solid neoplasm

Chemotherapeutic Agent Toxicity

NCT01088620 2013-03-14

Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer

WiSP Wissenschaftlicher Service Pharma GmbH

Phase 2 Suspended
134 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡